{"id":"NCT00783224","sponsor":"Organon and Co","briefTitle":"A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)","officialTitle":"Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2005-11","completion":"2005-12","firstPosted":"2008-10-31","resultsPosted":"2010-07-12","lastUpdate":"2022-02-09"},"enrollment":351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Placebo for MF","otherNames":[]},{"type":"DRUG","name":"Placebo for FP","otherNames":[]},{"type":"DRUG","name":"Mometasone","otherNames":["SCH 032088","Nasonex"]},{"type":"DRUG","name":"Fluticasone","otherNames":["Flonase"]}],"arms":[{"label":"Mometasone Furoate Placebo (PLAMF)","type":"PLACEBO_COMPARATOR"},{"label":"Fluticasone Propionate Placebo (PLAFP)","type":"PLACEBO_COMPARATOR"},{"label":"Mometasone Furoate (MF)","type":"EXPERIMENTAL"},{"label":"Fluticasone Propionate (FP)","type":"ACTIVE_COMPARATOR"}],"summary":"This study was conducted to see if mometasone nasal spray is efficaceous for the treatment of perennial allergic rhinitis. Patients will be randomized to active mometasone, placebo mometasone, active fluticasone, or placebo fluticasone.","primaryOutcome":{"measure":"Change in 4 Nasal Symptom Score (Sneezing Attack, Rhinorrhea, Nasal Congestion, and Nasal Itching) After 2 Weeks","timeFrame":"Baseline to 2 weeks of treatment","effectByArm":[{"arm":"Mometasone Furoate Placebo (PLAMF)","deltaMin":7.84,"sd":0.25},{"arm":"Fluticasone Propionate Placebo (PLAFP)","deltaMin":8.41,"sd":0.29},{"arm":"Mometasone Furoate (MF)","deltaMin":8.27,"sd":0.15},{"arm":"Fluticasone Propionate (FP)","deltaMin":8.29,"sd":0.16}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0001"},{"comp":"OG001 vs OG003","p":"0.0001"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":66},"commonTop":["Upper Respiratory Tract Inflammation"]}}